Join Growin Stock Community!

Newgenivf group limitedNIVF.US Overview

US StockHealthcare
(No presentation for NIVF)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NIVF AI Insights

NIVF Overall Performance

NIVF AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NIVF Recent Performance

-4.83%

Newgenivf group limited

0.05%

Avg of Sector

-0.31%

S&P500

NIVF PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NIVF Key Information

NIVF Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NIVF Profile

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Price of NIVF

NIVF FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NIVF Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-14.10
PE Ratio (TTM)
0.00
Forward PE
-
PS Ratio (TTM)
0.18
PB Ratio
0.03
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
32.57%
Net Margin
-6.49%
Revenue Growth (YoY)
-34.49%
Profit Growth (YoY)
-42.02%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-14.10
PE Ratio (TTM)
0.00
Forward PE
-
PS Ratio (TTM)
0.18
PB Ratio
0.03
Price-to-FCF
-
Gross Margin
32.57%
Net Margin
-6.49%
Revenue Growth (YoY)
-34.49%
Profit Growth (YoY)
-42.02%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is NIVF's latest earnings report released?

    The most recent financial report for Newgenivf group limited (NIVF) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NIVF's short-term business performance and financial health. For the latest updates on NIVF's earnings releases, visit this page regularly.

  • How much debt does NIVF have?

    As of the end of the reporting period, Newgenivf group limited (NIVF) had total debt of 4.43M, with a debt ratio of 0.3. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does NIVF have?

    At the end of the period, Newgenivf group limited (NIVF) held Total Cash and Cash Equivalents of 1.61M, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.